Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Groop

Showing results (121-130 of 242) with videos related to

Pageof 25
Sort By:
Acta Diabetologica|April 1, 1994
The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patientsC Saloranta, L Groop, A Ekstrand, et al.
Transplantation Proceedings|February 1, 1987
Results of kidney transplantation in patients with diabetic nephropathyA Ekstrand, C Grönhagen-Riska, L Groop, et al.
Diabetologia|March 1, 1995
Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study GroupP Knudsen, J Eriksson, S Lahdenperä, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1993
Insulin receptor isotype expression correlates with risk of non-insulin-dependent diabetesL Mosthaf, J Eriksson, H U Häring, et al.
Diabetes|November 1, 1993
Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDMC Saloranta, M R Taskinen, E Widen, et al.
Diabetologia|January 11, 2001
Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic stateD Tripathy, A L Carlsson, M Lehto, et al.
Diabetologia|April 6, 2002
Polymorphism in the Calpain 10 gene influences glucose metabolism in human fat cellsJ Hoffstedt, M Rydén, P Löfgren, et al.
Diabetologia|September 27, 2012
Effect of a common variant of the PCSK2 gene on reduced insulin secretionA Jonsson, B Isomaa, T Tuomi, et al.
The American Journal of Medicine|August 1, 1989
Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapyL Groop, C Schalin, A Franssila-Kallunki, et al.
Diabetologia|October 13, 2001
The metabolic syndrome influences the risk of chronic complications in patients with type II diabetesB Isomaa, M Henricsson, P Almgren, et al.
Pageof 25

Showing results (121-130 of 242) with videos related to

Sort By:
Pageof 25
Acta Diabetologica|April 1, 1994
The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patientsC Saloranta, L Groop, A Ekstrand, et al.
Transplantation Proceedings|February 1, 1987
Results of kidney transplantation in patients with diabetic nephropathyA Ekstrand, C Grönhagen-Riska, L Groop, et al.
Diabetologia|March 1, 1995
Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study GroupP Knudsen, J Eriksson, S Lahdenperä, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1993
Insulin receptor isotype expression correlates with risk of non-insulin-dependent diabetesL Mosthaf, J Eriksson, H U Häring, et al.
Diabetes|November 1, 1993
Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDMC Saloranta, M R Taskinen, E Widen, et al.
Diabetologia|January 11, 2001
Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic stateD Tripathy, A L Carlsson, M Lehto, et al.
Diabetologia|April 6, 2002
Polymorphism in the Calpain 10 gene influences glucose metabolism in human fat cellsJ Hoffstedt, M Rydén, P Löfgren, et al.
Diabetologia|September 27, 2012
Effect of a common variant of the PCSK2 gene on reduced insulin secretionA Jonsson, B Isomaa, T Tuomi, et al.
The American Journal of Medicine|August 1, 1989
Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapyL Groop, C Schalin, A Franssila-Kallunki, et al.
Diabetologia|October 13, 2001
The metabolic syndrome influences the risk of chronic complications in patients with type II diabetesB Isomaa, M Henricsson, P Almgren, et al.
Pageof 25